EFL1 and breast carcinoma: In our work, EFL1 reduced liver metastasis and mesenteric re-metastasis of breast cancer cells, enhanced liver function and mitigated ascites in breast cancer SHI mice, reflecting the potential of EFL1 in treating breast cancer liver metastasis.